Patient dose during therapeutic endoscopic retrograde cholangiopancreatography procedure

Research output: Contribution to journalArticlepeer-review

Abstract

Endoscopic retrograde cholangiopancreatography (ERCP) is a standard technique for the diagnosis and treatment of disorders of the pancreas or bile ducts. The aim of this study was the measurement of the radiation dose to patients during therapeutic ERCP procedures, in order to estimate the patient effective dose (ED). Fifteen patients were studied using a fluoroscopy system equipped with automatic brightness control and pulse fluoroscopy mode. Fluoroscopy time (FT), cumulative dose (Ka, r) and air kerma-area product (PKA) were collected for ERCP procedures. The ED was calculated from PKA values. The FT was ranged from 0.68 to 5.57 min, with the mean value of 2.50 min; the Ka, r was ranged from 2.22 to 19.10 mGy, with the mean value of 7.71 mGy; and the PKA was ranged between 0.59 and 5.10 Gycm2, with the mean value of 2.03 Gycm2. The ED ranged from 0.11 to 0.97 mSv, whilst the mean and median ED values were 0.39 and 0.32 mSv, respectively. FT and radiation dose to the patients were either comparative or significantly lower than those previously reported.

Original languageEnglish
Article numberncw023
Pages (from-to)380-382
Number of pages3
JournalRadiation Protection Dosimetry
Volume173
Issue number4
DOIs
Publication statusPublished - 15 Apr 2017
Externally publishedYes

Fingerprint

Dive into the research topics of 'Patient dose during therapeutic endoscopic retrograde cholangiopancreatography procedure'. Together they form a unique fingerprint.

Cite this